001     176936
005     20240229133725.0
024 7 _ |a 10.3389/fgene.2021.693933
|2 doi
024 7 _ |a pmid:34527018
|2 pmid
024 7 _ |a pmc:PMC8435735
|2 pmc
024 7 _ |a altmetric:112579256
|2 altmetric
037 _ _ |a DKFZ-2021-02176
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Lu, Ye
|0 P:(DE-He78)ebb819874e9553d89bd480e6811dc0f3
|b 0
|e First author
|u dkfz
245 _ _ |a Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk.
260 _ _ |a Lausanne
|c 2021
|b Frontiers Media
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1634036444_10607
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:C055#LA:C055#
520 _ _ |a Genetic factors play an important role in the susceptibility to pancreatic cancer (PC). However, established loci explain a small proportion of genetic heritability for PC; therefore, more progress is needed to find the missing ones. We aimed at identifying single nucleotide polymorphisms (SNPs) affecting PC risk through effects on micro-RNA (miRNA) function. We searched in silico the genome for SNPs in miRNA seed sequences or 3 prime untranslated regions (3'UTRs) of miRNA target genes. Genome-wide association data of PC cases and controls from the Pancreatic Cancer Cohort (PanScan) Consortium and the Pancreatic Cancer Case-Control (PanC4) Consortium were re-analyzed for discovery, and genotyping data from two additional consortia (PanGenEU and PANDoRA) were used for replication, for a total of 14,062 cases and 11,261 controls. None of the SNPs reached genome-wide significance in the meta-analysis, but for three of them the associations were in the same direction in all the study populations and showed lower value of p in the meta-analyses than in the discovery phase. Specifically, rs7985480 was consistently associated with PC risk (OR = 1.12, 95% CI 1.07-1.17, p = 3.03 × 10-6 in the meta-analysis). This SNP is in linkage disequilibrium (LD) with rs2274048, which modulates binding of various miRNAs to the 3'UTR of UCHL3, a gene involved in PC progression. In conclusion, our results expand the knowledge of the genetic PC risk through miRNA-related SNPs and show the usefulness of functional prioritization to identify genetic polymorphisms associated with PC risk.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a genetic polymorphisms
|2 Other
650 _ 7 |a miRNA
|2 Other
650 _ 7 |a pancreatic cancer
|2 Other
650 _ 7 |a pancreatic ductal adenocarcinoma
|2 Other
650 _ 7 |a susceptibility
|2 Other
700 1 _ |a Corradi, Chiara
|b 1
700 1 _ |a Gentiluomo, Manuel
|b 2
700 1 _ |a López de Maturana, Evangelina
|b 3
700 1 _ |a Theodoropoulos, George E
|b 4
700 1 _ |a Roth, Susanne
|b 5
700 1 _ |a Maiello, Evaristo
|b 6
700 1 _ |a Morelli, Luca
|b 7
700 1 _ |a Archibugi, Livia
|b 8
700 1 _ |a Izbicki, Jakob R
|b 9
700 1 _ |a Sarlós, Patricia
|b 10
700 1 _ |a Kiudelis, Vytautas
|b 11
700 1 _ |a Oliverius, Martin
|b 12
700 1 _ |a Aoki, Mateus Nóbrega
|b 13
700 1 _ |a Vashist, Yogesh
|b 14
700 1 _ |a van Eijck, Casper H J
|b 15
700 1 _ |a Gazouli, Maria
|b 16
700 1 _ |a Talar-Wojnarowska, Renata
|b 17
700 1 _ |a Mambrini, Andrea
|b 18
700 1 _ |a Pezzilli, Raffaele
|b 19
700 1 _ |a Bueno-de-Mesquita, Bas
|b 20
700 1 _ |a Hegyi, Péter
|b 21
700 1 _ |a Souček, Pavel
|b 22
700 1 _ |a Neoptolemos, John P
|b 23
700 1 _ |a Di Franco, Gregorio
|b 24
700 1 _ |a Sperti, Cosimo
|b 25
700 1 _ |a Kauffmann, Emanuele F
|b 26
700 1 _ |a Hlaváč, Viktor
|b 27
700 1 _ |a Uzunoğlu, Faik G
|b 28
700 1 _ |a Ermini, Stefano
|b 29
700 1 _ |a Małecka-Panas, Ewa
|b 30
700 1 _ |a Lucchesi, Maurizio
|b 31
700 1 _ |a Vanella, Giuseppe
|b 32
700 1 _ |a Dijk, Frederike
|b 33
700 1 _ |a Mohelníková-Duchoňová, Beatrice
|b 34
700 1 _ |a Bambi, Franco
|b 35
700 1 _ |a Petrone, Maria Chiara
|b 36
700 1 _ |a Jamroziak, Krzysztof
|b 37
700 1 _ |a Guo, Feng
|0 P:(DE-He78)0311ebf3415e41860b4e2c56fbae6919
|b 38
|u dkfz
700 1 _ |a Kolarova, Katerina
|b 39
700 1 _ |a Capretti, Giovanni
|b 40
700 1 _ |a Milanetto, Anna Caterina
|b 41
700 1 _ |a Ginocchi, Laura
|b 42
700 1 _ |a Loveček, Martin
|b 43
700 1 _ |a Puzzono, Marta
|b 44
700 1 _ |a van Laarhoven, Hanneke W M
|b 45
700 1 _ |a Carrara, Silvia
|b 46
700 1 _ |a Ivanauskas, Audrius
|b 47
700 1 _ |a Papiris, Konstantinos
|b 48
700 1 _ |a Basso, Daniela
|b 49
700 1 _ |a Arcidiacono, Paolo G
|b 50
700 1 _ |a Izbéki, Ferenc
|b 51
700 1 _ |a Chammas, Roger
|b 52
700 1 _ |a Vodicka, Pavel
|b 53
700 1 _ |a Hackert, Thilo
|b 54
700 1 _ |a Pasquali, Claudio
|b 55
700 1 _ |a Piredda, Maria L
|b 56
700 1 _ |a Costello-Goldring, Eithne
|b 57
700 1 _ |a Cavestro, Giulia Martina
|b 58
700 1 _ |a Szentesi, Andrea
|b 59
700 1 _ |a Tavano, Francesca
|b 60
700 1 _ |a Włodarczyk, Barbara
|b 61
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 62
|u dkfz
700 1 _ |a Kreivenaite, Edita
|b 63
700 1 _ |a Gao, Xin
|0 P:(DE-He78)8218df9f6f41792399cd3a29b587e4e7
|b 64
|u dkfz
700 1 _ |a Bunduc, Stefania
|b 65
700 1 _ |a Vermeulen, Roel C H
|b 66
700 1 _ |a Schneider, Martin A
|b 67
700 1 _ |a Latiano, Anna
|b 68
700 1 _ |a Gioffreda, Domenica
|b 69
700 1 _ |a Testoni, Sabrina G G
|b 70
700 1 _ |a Kupcinskas, Juozas
|b 71
700 1 _ |a Lawlor, Rita T
|b 72
700 1 _ |a Capurso, Gabriele
|b 73
700 1 _ |a Malats, Núria
|b 74
700 1 _ |a Campa, Daniele
|b 75
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 76
|e Last author
|u dkfz
773 _ _ |a 10.3389/fgene.2021.693933
|g Vol. 12, p. 693933
|0 PERI:(DE-600)2606823-0
|p 693933
|t Frontiers in genetics
|v 12
|y 2021
|x 1664-8021
909 C O |o oai:inrepo02.dkfz.de:176936
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)ebb819874e9553d89bd480e6811dc0f3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 38
|6 P:(DE-He78)0311ebf3415e41860b4e2c56fbae6919
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 62
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 64
|6 P:(DE-He78)8218df9f6f41792399cd3a29b587e4e7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 76
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT GENET : 2019
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-05-04
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-05-04
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-05-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-05-04
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-05-04
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-05-04
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-05-04
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 2
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21